Department of Ophthalmology, Dicle University Faculty of Medicine, Diyarbakir, Turkey.
J Ocul Pharmacol Ther. 2011 Dec;27(6):593-8. doi: 10.1089/jop.2011.0021. Epub 2011 Aug 11.
To evaluate the effects of intravitreal moxifloxacin with or without dexamethasone on experimental Bacillus cereus endophthalmitis.
The right eyes of 21 New Zealand albino rabbits weighing 2-3 kg were used in this study. Each eye was inoculated with 1×10(6) colony-forming units of B. cereus microorganisms via intravitreal injection into the vitreous cavity, and an experimental model of B. cereus endophthalmitis was formed. The rabbits were separated into 3 groups: Group 1 was given 0.1 mL of balanced saline solution intravitreally, group 2 was given 50 μg of moxifloxacin, and group 3 was given 50 μg of moxifloxacin plus 400 μg of dexamethasone 24 h after the inoculation. Vitreous aspirates were taken for microbiological examination on the 3rd day. Clinical inflammation scores were evaluated on days 1, 7, and 14. The rabbits were killed on the 14th day, and the eyes were enucleated for histopathological examination.
On the 7th day, only the vitreous scores of the treatment groups were significantly low compared with those of the control group (P<0.05). On day 14, the clinical scores of vitreous inflammation were 2.43±0.79, 1.43±0.53, and 1.29±0.49 in Groups 1, 2, and 3, respectively. The clinical scores of the treatment groups were significantly lower compared with those of the control group on day 14 (P<0.05). Histopathological scores were 2.43±0.79, 1.43±0.53, and 1.43±0.79 for the iris and 2.14±0.69, 1.57±0.53, and 1.14±0.38 for the vitreous in Groups 1, 2, and 3, respectively. Apart from the conjunctiva, the histopathological scores of the other tissues in the treatment groups were significantly lower compared with those of the control group (P<0.05). No significant differences were found in the histopathological or clinical scores among the treatment groups (P>0.05). Microbiological scores at day 14 were 151±6.43, 125.43±13.44, and 131.14±16.99 for Groups 1, 2, and 3, respectively. The microbiological scores of the treatment groups were significantly lower compared with those of the control group (P<0.05).
Intravitreal moxifloxacin injection is effective in experimental B. cereus endophthalmitis. The addition of intravitreal dexamethasone may not significantly affect treatment efficacy.
评估玻璃体内莫西沙星联合或不联合地塞米松对实验性蜡样芽孢杆菌眼内炎的疗效。
本研究使用 21 只 2-3 公斤重的新西兰白兔的右眼。通过玻璃体内注射将 1×10(6)个蜡样芽孢杆菌微生物菌落形成单位接种到玻璃体腔中,形成蜡样芽孢杆菌眼内炎实验模型。将兔子分为 3 组:第 1 组玻璃体内注射 0.1 mL 平衡盐溶液,第 2 组玻璃体内注射 50 μg 莫西沙星,第 3 组在接种后 24 小时玻璃体内注射 50 μg 莫西沙星和 400 μg 地塞米松。第 3 天取玻璃体进行微生物学检查。第 1、7 和 14 天评估临床炎症评分。第 14 天处死兔子,眼球摘出进行组织病理学检查。
第 7 天,仅治疗组的玻璃体评分明显低于对照组(P<0.05)。第 14 天,各组玻璃体炎症的临床评分分别为 2.43±0.79、1.43±0.53 和 1.29±0.49。治疗组的临床评分明显低于对照组(P<0.05)。虹膜的组织病理学评分分别为 2.43±0.79、1.43±0.53 和 1.43±0.79,玻璃体的组织病理学评分分别为 2.14±0.69、1.57±0.53 和 1.14±0.38。除结膜外,治疗组的其他组织的组织病理学评分均明显低于对照组(P<0.05)。治疗组之间的组织病理学或临床评分无显著差异(P>0.05)。第 14 天的微生物学评分分别为 151±6.43、125.43±13.44 和 131.14±16.99。治疗组的微生物学评分明显低于对照组(P<0.05)。
玻璃体内注射莫西沙星对实验性蜡样芽孢杆菌眼内炎有效。玻璃体内添加地塞米松可能不会显著影响治疗效果。